ArticleJournal of food science2026
Mechanistic Insights Into Wall-Breaking Selenium-Enriched Yeast Intervention on Glycolipid Homeostasis in Type 2 Diabetic Rats Through Gut Microbiota Modulation.
Article in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Type 2 diabetes mellitus (T2DM), a metabolic disorder closely associated with dietary factors, exhibits potential pathogenic links with gut microbiota dysbiosis. This study investigated the therapeutic potential of wall-breaking selenium-enriched yeast (WBS) through systematic exploration of its regulatory mechanisms on metabolism and gut microbiota in streptozotocin-induced T2DM rat models. Key findings revealed that the WBS effectively elevated selenium levels in serum and major tissues. Therapeutically, considerable improvements were observed in blood glucose-related parameters and glycolipid metabolism, alongside enhanced pancreatic function and antioxidant enzyme activities. Histopathological examination demonstrated attenuated fibrosis in liver and kidneys, accompanied by their functional restoration. Moreover, WBS reversed T2DM-induced gut dysbiosis, particularly enriching bacteria including Bacteroidota and Ruminococcus. Concurrently, fecal SCFA content showed marked elevation. The anti-inflammatory effects were evidenced by downregulated colonic inflammatory cytokines and related mRNA expressions. These findings provide theoretical foundation for developing selenium-enriched yeast products and formulating nutritional strategies for T2DM intervention. PRACTICAL APPLICATIONS: The findings of this study help clarify the role of selenium-enriched yeast in modulating dysregulated glycolipid metabolism in Type 2 diabetes through the gut microbiota.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.